Which Should Be Used First for ALK-Positive Non-Small-Cell Lung Cancer: Chemotherapy or Targeted Therapy? A Meta-Analysis of Five Randomized Trials.

MLA

Lee, Yen-Chien, et al. “Which Should Be Used First for ALK-Positive Non-Small-Cell Lung Cancer: Chemotherapy or Targeted Therapy? A Meta-Analysis of Five Randomized Trials.” Medicina (Kaunas, Lithuania), vol. 55, no. 2, Jan. 2019. EBSCOhost, https://doi.org/10.3390/medicina55020029.

APA

Lee, Y.-C., Hsieh, C.-C., Lee, Y.-L., & Li, C.-Y. (2019). Which Should Be Used First for ALK-Positive Non-Small-Cell Lung Cancer: Chemotherapy or Targeted Therapy? A Meta-Analysis of Five Randomized Trials. Medicina (Kaunas, Lithuania), 55(2). https://doi.org/10.3390/medicina55020029

Chicago

Lee, Yen-Chien, Chung-Cheng Hsieh, Yen-Ling Lee, and Chung-Yi Li. 2019. “Which Should Be Used First for ALK-Positive Non-Small-Cell Lung Cancer: Chemotherapy or Targeted Therapy? A Meta-Analysis of Five Randomized Trials.” Medicina (Kaunas, Lithuania) 55 (2). doi:10.3390/medicina55020029.